Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this crossover trial is to compare the 3-month, mean 24-hour
intraocular pressure (IOP) control and safety obtained with two popular fixed combinations in
glaucoma patients insufficiently controlled with latanoprost monotherapy. This study will
compare the 24-hour efficacy of travoprost/timolol fixed combination without benzalkonium
chloride given once in the evening, versus the latanoprost/timolol fixed combination given in
the evening. It is assumed that travoprost/timolol fixed combination will provide better
quality of 24-hour pressure control.